Klaas Wierenga, MD
Clinical Genetics (M.D.) · Gainesville, FLNPI 1548363724
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,200 of the $5,250 with a category attached, or 61.0%. Ultragenyx Pharmaceutical Inc. accounts for 61.5% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $4,805 and has fallen 99.0% since, to $47 in 2024.
Across 13 payments — averaging $403.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ultragenyx Pharmaceutical Inc.$3K
- AstraZeneca$2K
- Biomarin Pharmaceutical Inc.$230
- PTC Therapeutics, Inc.$123
- Travere Therapeutics, Inc.$49
Across 21 payments — averaging $1968.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astellas Pharma Inc$33K
- AstraZeneca$9K
What the payments were for
- Consulting fees$3,20061%
- Speaking & faculty fees$1,57530%
- Food & beverage$4438%
- Education$321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 2 | $3,230 |
| AstraZeneca | 2 | $1,618 |
| Biomarin Pharmaceutical Inc. | 4 | $230 |
| PTC Therapeutics, Inc. | 2 | $123 |
| Travere Therapeutics, Inc. | 3 | $49 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,250 in reported general payments places this provider in the 80th percentile of 37 clinical genetics (m.d.) providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical genetics (m.d.) in Gainesville
- Roberto ZoriGainesville$169K
- Daniel DriscollGainesville$189
- Charles WilliamsGainesville$154
- Amarilis Sanchez ValleTampa$166K
- Paldeep AtwalWest Palm Beach$121K
- Parul JayakarMiami$82K
- Deborah BarbouthMiami$40K
- Ingrid CristianOrlando$38K
- Maria DescartesFort Myers$9K
- Irman ForghaniMiami$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.